Seminar summary: https://foresight.org/summary/bioelectric-networks-taming-th…-medicine/
Program & apply to join: https://foresight.org/biotech-health-extension-program/
Foresight Biotech & Health Extension Meeting sponsored by 100 Plus Capital.
Age catches up with us all eventually, but in some people the right genes can make that chase into our twilight years a relatively leisurely one.
A few years ago Italian researchers discovered something special about people who live well into their 90s and beyond: they commonly have a version of a gene called BPIFB4 that protects against cardiovascular damage and keeps the heart in good shape for a longer period of time.
By introducing the mutated gene into older mice, the scientists have now seen how the variant rewinds markers of biological heart aging by the equivalent of more than 10 human years.
Bryan Johnson is 45 years old but, according to a new report, his test results show he has the heart of a 37-year-old and the lungs of a young adult.
Johnson is a biotech entrepreneur who hopes to game nature’s course of aging and have the organs and health of an 18-year-old by going through an intense data-driven experimental program he’s called Project Blueprint.
According to a recent Bloomberg profile of the CEO, Johnson could spend up to $2 million on his body this year and there are early glimpses that show he may be on track to unlocking the secret to age reversal.
Does the secret to reaching extreme old age lie in lifestyle or genetics? Story at a glance America’s population is aging, with more people living to be 100. Reaching extreme old age depends on multiple factors like location, gender, lifestyle and parental age of death.
Phil Newman, Founder and CEO, Longevity. Technology at Rejuvenation Startup Summit 2022.
Connect to Forever Healthy:
* Videos: https://forever-healthy.org/videos/
* News: https://forever-healthy.org/news/
* LinkedIn: https://www.linkedin.com/company/forever-healthy-foundation/
Advancing Geroscience & Gerotherapeutics — Dr. Nir Barzilai, MD, Albert Einstein College of Medicine.
Dr. Nir Barzilai, MD (https://www.einsteinmed.edu/faculty/484/nir-barzilai/) is the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics.
Rejuvenating an older person’s blood may now be within reach, based on recent findings from Passegué’s lab published in Nature Cell Biology(link is external and opens in a new window).
Passegué, with her graduate student Carl Mitchell, found that an anti-inflammatory drug, already approved for use in rheumatoid arthritis, can turn back time in mice and reverse some of the effects of age on the hematopoietic system.
Nature article:
Continue reading “Will Revitalizing Old Blood Slow Aging?” »
Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD
Green Tea Discount Link.
https://www.ochaandco.com/?ref=conqueraging.
Continue reading “Quantifying Biological Age: Blood Test #1 in 2023” »
How should we live when we know we must die? This question is posed by the first work of world literature, the Gilgamesh epic. More than 4,000 years ago, Gilgamesh set out on a quest for immortality. Like all Babylonian literature, the saga has survived only in fragments. Nevertheless, scholars have managed to bring two-thirds of the text into readable condition since it was rediscovered in the 19th century.
The Babylonians wrote in cuneiform characters on clay tablets, which have survived in the form of countless fragments. Over centuries, scholars transferred the characters imprinted on the pieces of clay onto paper. Then they would painstakingly compare their transcripts and—in the best case—recognize which fragments belong together and fill in the gaps. The texts were written in the languages Sumerian and Akkadian, which have complicated writing systems. This was a Sisyphean task, one that the experts in the Electronic Babylonian Literature project can scarcely imagine today.
Enrique Jiménez, Professor of Ancient Near Eastern Literatures at LMU’s Institute of Assyriology, and his team have been working on the digitization of all surviving cuneiform tablets since 2018. In that time, the project has processed as many as 22,000 text fragments.
This is more about the current landscape but a bit on the future near the beginning.
In this video Dr de Grey talks the future of LEVF and how the longevity field has evolved and some of the main participants.
Continue reading “The Longevity Field Now And In The Future | Dr Aubrey de Grey 2 Ep 4” »
